{
}
Express Scripts, Caremark, and OptumRx are suing the FTC, claiming the agency is unlawfully attempting to reform drug rebate contracts amid allegations of anticompetitive practices related to insulin pricing. The PBMs argue that the FTC's actions threaten their ability to negotiate lower drug costs and could reshape the entire industry through enforcement rather than legislation.
Dr. Mehmet Oz, nominated by President Trump to lead the Centers for Medicare & Medicaid Services, faces potential conflicts of interest due to his substantial investments in health care, tech, and food companies, including UnitedHealth Group and Amazon. His financial ties raise questions about his ability to act in the public's interest, especially as he advocates for Medicare Advantage, a program that could significantly impact his wealth. Critics highlight the challenges of managing these conflicts, noting that past nominees have divested similar holdings to avoid ethical dilemmas.
Pharmacy benefit managers (PBMs) are challenging the Federal Trade Commission's (FTC) recent lawsuit, claiming it undermines the Constitution by attempting to reshape the industry through regulatory means. The FTC alleges that PBMs inflate insulin costs, while the PBMs argue they lower net drug prices and shift blame to manufacturers. They contend that the FTC's actions infringe on private contracts and assert excessive executive power, with the case set for a hearing in August 2025.
CVS Health, UnitedHealth Group, and Cigna have filed a lawsuit against the FTC, claiming the agency"s case regarding high insulin prices is unconstitutional. The companies argue that the FTC"s administrative process violates their due process rights and is fundamentally unfair, as it lacks democratic accountability. The FTC maintains that the practices of these pharmacy benefit managers harm patients by inflating costs for essential medications.
Orthopedic providers have filed a federal lawsuit against Elevance, UnitedHealthcare, and other insurers, alleging a multibillion-dollar price-fixing scheme with MultiPlan to suppress out-of-network payment rates to doctors. The complaint claims that insurers collectively outsource rate-setting to MultiPlan, violating antitrust laws, while MultiPlan"s algorithmic compensation determination is described as a facade for traditional price-fixing. The lawsuit seeks class action status, a jury trial, and a judgment declaring the conduct unlawful.
The convergence of science and technology is transforming healthcare, with Syfe's Healthcare Innovation portfolio offering diversified investment across genomics, biotechnology, pharmaceuticals, healthcare services, and medical devices. This portfolio includes six carefully selected ETFs, providing exposure to leading companies and innovations in the sector, while managing risks associated with long-term healthcare investments. With no minimum investment and low fees, it aims to capitalize on the future of healthcare advancements.
Cigna
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
pharmacy benefit managers sue ftc over insulin pricing lawsuit
20:49 22.11.2024
dr oz's potential conflicts of interest as cms administrator nominee
United States Dollar
CVS Health Corporation
Wawa
Domino's Pizza, Inc.
Amazon.com, Inc.
One Medical
Cigna
UnitedHealth Group Incorporated
US Foods Holding Corp.
Aetna
PepsiCo, Inc.
USA
John Fetterman
Donald Trump
Merrick Garland
Janet Yellen
Mehmet Oz
Jeffrey Singer
Show more
17:00 22.11.2024
pharmacy benefit managers challenge ftc over alleged unconstitutional practices
Cigna
CVS Health Corporation
UnitedHealth Group Incorporated
USA
Matt Gaetz
Lina Khan
JD Vance
Show more
20:34 20.11.2024
pharmacy benefit managers challenge ftc case over insulin pricing practices
21:31 19.11.2024
insurers accused of price fixing in multibillion dollar lawsuit
United States Dollar
Aetna
Cigna
Highmark
UnitedHealthcare
USA
Curtis F. Robinson
John Fedele
Show more
18:01 19.11.2024
healthcare innovation portfolio targets advancements in pharmaceuticals and medical technologies
Masimo Corporation
Vertex Pharmaceuticals Incorporated
Abbott Laboratories
GE HealthCare Technologies Inc.
AtriCure, Inc.
Regeneron Pharmaceuticals, Inc.
Intuitive Surgical, Inc.
CRISPR Therapeutics AG
Veeva Systems Inc.
Johnson & Johnson
Cigna
Integra LifeSciences Holdings Corporation
CVS Health Corporation
Stryker Corporation
UnitedHealth Group Incorporated
Amgen Inc.
Penumbra, Inc.
Alphatec Holdings, Inc.
UCB SA
Boston Scientific Corporation
Eli Lilly and Company
USA
BEL
Beigene
Revolution Medicines
Gilead Sciences
Exelixis
Incyte
Show more
02:52 13.11.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Private Equity Deals
Retail and Consumer Goods
Supply Chain Management
Government Economic Policies
Fintech Startups
Venture Capital Investments
Inflation and Monetary Impact
CEO Changes
Finance Mergers & Acquisitions
AI Innovations
Emerging Startups
Workplace Trends
Energy Sector Developments
Economic Indicators
Countries:
Companies:
Apple Inc.
Google Inc.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
NIO Inc.
Nikkei 225
Delhivery Limited
Ecom Express Ltd.
Nintendo Co., Ltd.
EFG Hermes Egypt
Microsoft Corporation
Eurasia Groupe SA
British International Investment plc
XPeng Inc.
Li Auto Inc.
Morgan Stanley
Taiwan Semiconductor Manufacturing Company Limited
VFS Global AG
LARGAN Precision Co.,Ltd
S&P/ASX 200
Currencies:
United States Dollar
Indian Rupee
Euro
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
South Korean Won
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
Egyptian Pound
People: